Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Table 2 Content of the questionnaires of the SALT Osteoporosis Study

Theme	Questionnaire
Fractures	Q1, Q2, Q3
Examination for osteoporosis	Q1, Q2, Q3
Hip fractures of close family	Q1, Q2, Q3
Falls in last 12 months	Q1, Q2, Q3
Fear of falling	Q1, Q2, Q3
Mobility and use of walking aid	Q1, Q2, Q3
Height and weight	Q1, Q2, Q3
Living situation	Q1, Q2, Q3
Education level	Q1
Ethnicity	Q1
Age of start menopause	Q1
Smoking and alcohol use	Q1, Q2, Q3
Use of dairy products	Q1, Q2, Q3
Use of vitamin D/ calcium/ multi-vitamin supplements	Q1, Q2, Q3
Medication use	Q1, Q2, Q3
Use of osteoporosis medication	Q1, Q2, Q3
Prednison use	Q1
Chronic diseases	Q1, Q2, Q3
Quality of life (EuroQoL-5D)	Q2, Q3
Consultation physician	Q2, Q3
Hospital admission	Q2, Q3
Dizziness	Q2
Incontinence	Q2
Memory complaints	Q2
Depression and anxiety (PHQ-4)	Q2
Attitude toward osteoporosis and perceived risks	Q2
Adherence and persistence to use osteoporosis medication (ADEOS-12)	Q2^a
Side effects of osteoporosis medication	Q2^a
Independence	Q3
Diabetes treatment	Q3^b
Diabetes complications and hypoglycaemic attacks	Q3^b
Sunlight exposure	QD^c
Vitamin D via diet and supplements	QD^c

Q1 baseline questionnaire, Q2 questionnaire after 18 months, Q3 questionnaire after 36 months, QD = vitamin D questionnaire. ^aThese items are questioned only to patients with an indication for treatment. ^bThese items are questioned only to patients with diabetes mellitus. ^cThis questionnaire has been send to a random sample of the first participants